The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Nobody knows what’s going on behind the scenes. Let them do their stuff I say. I don’t think they should or will be releasing RNS’s each sale from now on. I wouldn’t be surprised if they take a couple of months now to formulate a meaningful update regarding sales/interest for investors.
Just keep loading up on shares when you can afford it, whatever the SP. This will be gobbled up quickly between 2-3 years and the SP will sizzle before hand. Those that try and sell and rebuy for a quick buck might get burnt.
I agree with all of the above, in my view Polarean has now reached the stage in which it is ready to introduce the product to the healthcare market. The market is there and waiting, this product will sell. There is a decade of evidence to support this, many institutions have wanted this imaging technique and have facilitated the research in discovering its capabilities when applied to a variety of lung conditions. By how much in profit terms is up for debate on this board, the significant investors know this will take 1-2 years after approval to find out (at least). The 2 major setbacks (1st crl and extension) have made new investors weary. All the hype currently is now focused on approval, but that's just the beginning. The reality is that many investors are after the next 'quick buck' and are not prepared wait for this to mature. I've have read the many scholarly articles relating to this technology as I'm sure you all have, the common theme in conclusions is that it's an exciting, high potential, and crucial diagnostic tool for clinicians. The first hurdle is accessing the tough and competitive US market. We only have to wait a tiny bit longer to get a bit of insight on where this will go.
This stagnant SP this close to the big RNS makes me feel that everybody who wants to be invested in this already are. Would be nice to get a bit of a rise soon.
Big fish waiting for a slight nudge of encouragement from sources close to Polarean team? Any thoughts
I’m wondering if anyone can help run over the history of Polarean to me to fill in the gaps I am unaware of.
I’ve been very keen on this stock since discovering it 2 years ago, I’ve read a number of the scholarly articles from the universities that currently have their polariser (and there is quite a lot). All promising results as we know. But I came across a podcast on BBC sounds from 2013 talking about the clinical research Oxford has been doing with it. (Talking about the tech as if it were their own.) no mention of Polarean.
When did the company form before going public?
What’s changed since 2013 / 2018 onwards. And does anyone have any in depth knowledge of the research studies, outcomes? Or recommendations of any significant studies ?
I know many respiratory clinicians are begging this tech to be approved.
Extremely disappointing. Right, so effectively the new deadline will be the 30th December with that 90 days factored in?
Hard to remain committed to this company with these nit pickers in the FDA last minute finding something to dispute.